Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PEGLOTICASE
- Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
- A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
- Recapturing Immune Tolerance to Pegloticase for the Management of Tophaceous Gout
- A Phase I Clinical Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia
- A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)
- Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
- Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout
- A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Patients Refractory to Conventional Therapy
- Uric Acid Lowering Trial in Youth Onset T2D
- REduCing Immunogenicity to PegloticasE (RECIPE) Study
- Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect
- Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis
- Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
Clinical trials list
click for details